cancer panel Mar 19, 2020 Ovarian Cancer Mutational Signatures, Immune Features Tied to Combination Treatment Response Mar 12, 2020 Thermo Fisher, Janssen Biotech to Develop CDx for Lung Cancer, Other Indications Feb 13, 2020 Genetron Health Obtains Regulatory Approval in China for NGS Instrument, Lung Cancer Panel Feb 4, 2020 Maine Cancer Genomics Initiative Brings Precision Oncology to State's Cancer Patients Premium Sep 5, 2019 Large-Scale Multigene Panel Study of Hereditary Cancer Risk Refines Gene Associations Premium Mar 15, 2019 Academic, Community, and Health System Hospitals Face Unique Hurdles Implementing Precision Medicine Premium Feb 5, 2019 Foundation Medicine Gets $111.5M Genomic Profiling Contract From VA Department Aug 22, 2018 Study of Breast Cancer Risk Genes in Nigerian Women Suggests Benefits of Genetic Screening Apr 26, 2018 FDA Grants Breakthrough Device Designation to Foundation Medicine Liquid Biopsy Assay Oct 30, 2017 Gene Profiling Uncovers Actionable Mutations in More Than Half of Non-Small Cell Lung Cancers Jun 6, 2017 Hereditary Cancer Panel Study Suggests Germline Mutations Missed in Some Pancreatic Cancers Breaking News FDA Approves Taiho Oncology's Lytgobi for FGFR2-Rearranged Bile Duct Cancer Gladstone Institute Joins With Parker Institute on New Center to Study CRISPR-Based Cell Therapies Meliora Therapeutics Raises $11M in Seed Financing In Brief This Week:Â Verismo Therapeutics, Fore Biotherapeutics, Merck, Caris Life Sciences Tumor-Only Sequencing Found to Overestimate Mutational Burden in Non-European Patients Atara Biotherapeutics to Net $30M From Pierre Fabre for European Tab-Cel Approval
